Viewing Study NCT02467361


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2026-02-18 @ 3:46 AM
Study NCT ID: NCT02467361
Status: COMPLETED
Last Update Posted: 2023-11-14
First Post: 2015-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View